EMIL.NS(EMIL.NS)
EMIL.NS
$183.22—Stale · unknown old
NSE • Last print unknown ago
$183.22—Stale · unknown old
No analyst ratings available
No analyst price targets available for EMIL.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $85.49B | $97.16B | $112.68B |
| Low | $83.11B | $91.68B | $104.38B |
| High | $88.46B | $107.44B | $124.07B |
| EBITDA Avg | $6.10B | $6.63B | $7.97B |
| Low | $5.87B | $5.95B | $7.18B |
| High | $6.66B | $7.57B | $9.09B |
| EBIT Avg | $4.33B | $4.62B | $5.68B |
| Low | $4.10B | $3.94B | $4.88B |
| High | $4.89B | $5.57B | $6.80B |
| Net Income Avg | $2.29B | $2.51B | $3.30B |
| Low | $2.12B | $2.00B | $2.70B |
| High | $2.71B | $3.21B | $4.13B |
| EPS Avg | $6.06 | $6.62 | $8.60 |
| Low | $5.50 | $5.18 | $7.02 |
| High | $7.03 | $8.34 | $10.72 |
| Analysts (Rev / EPS) | 6 / 5 | 8 / 8 | 5 / 5 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $19.11B | $23.58B | $22.90B |
| Low | $19.11B | $23.58B | $22.90B |
| High | $19.11B | $23.58B | $22.90B |
| EBITDA Avg | $1.27B | $1.70B | $1.46B |
| Low | $1.27B | $1.70B | $1.46B |
| High | $1.27B | $1.70B | $1.46B |
| EBIT Avg | $851M | $1.26B | $1.01B |
| Low | $851M | $1.26B | $1.01B |
| High | $851M | $1.26B | $1.01B |
| Net Income Avg | $346M | $654M | $462M |
| Low | $346M | $654M | $462M |
| High | $346M | $654M | $462M |
| EPS Avg | $0.90 | $1.70 | $1.20 |
| Low | $0.90 | $1.70 | $1.20 |
| High | $0.90 | $1.70 | $1.20 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |